| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Pierre Sargis Sayad is Chief Medical Officer at FENC. Pierre Sargis Sayad's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $147K at current prices.
The FENC filings lean toward selling, a net 12,000 shares.
Pierre Sargis Sayad has 11 Form 4 filings on record from November 2024 to October 2026, all as Chief Medical Officer at Fennec Pharmaceuticals (FENC), 2024–2026.
The 15 reported transactions were 7 stock awards, 4 option exercises, 3 option or other derivative awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $146K.
The only open-market sale was 12,000 shares of FENC at an average $12.18 on August 31, 2026, about $146K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | FENC Fennec Pharmaceuticals Inc. | Chief Medical Officer | Sell | 12,000 | $12.18 | $146,160.00 | -55.8% | - | - |